Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 31, 2023

BUY
$98.98 - $115.74 $33,455 - $39,120
338 Added 29.7%
1,476 $170,000
Q2 2023

Jul 25, 2023

BUY
$96.34 - $112.38 $37,476 - $43,715
389 Added 51.94%
1,138 $117,000
Q1 2023

Apr 24, 2023

SELL
$107.32 - $113.5 $50,977 - $53,912
-475 Reduced 38.81%
749 $81,000
Q4 2022

Jan 25, 2023

SELL
$62.39 - $113.8 $9,046 - $16,501
-145 Reduced 10.59%
1,224 $0
Q3 2022

Oct 25, 2022

SELL
$58.92 - $84.67 $4.65 Million - $6.68 Million
-78,883 Reduced 98.29%
1,369 $85,000
Q2 2022

Aug 04, 2022

SELL
$79.4 - $116.36 $237,961 - $348,730
-2,997 Reduced 3.6%
80,252 $6.4 Million
Q1 2022

Apr 19, 2022

SELL
$86.42 - $109.81 $5,876 - $7,467
-68 Reduced 0.08%
83,249 $8.76 Million
Q4 2021

Feb 01, 2022

SELL
$98.56 - $119.91 $77,271 - $94,009
-784 Reduced 0.93%
83,317 $8.98 Million
Q3 2021

Oct 15, 2021

SELL
$91.91 - $110.37 $454,586 - $545,890
-4,946 Reduced 5.55%
84,101 $9.21 Million
Q2 2021

Aug 06, 2021

BUY
$86.24 - $95.92 $156,870 - $174,478
1,819 Added 2.09%
89,047 $8.34 Million
Q1 2021

May 07, 2021

BUY
$71.83 - $95.48 $6.19 Million - $8.22 Million
86,111 Added 7709.13%
87,228 $8.03 Million
Q4 2020

Feb 16, 2021

SELL
$67.0 - $84.39 $174,468 - $219,751
-2,604 Reduced 69.98%
1,117 $82,000
Q3 2020

Nov 09, 2020

SELL
$55.23 - $79.93 $325,415 - $470,947
-5,892 Reduced 61.29%
3,721 $289,000
Q2 2020

Aug 05, 2020

SELL
$30.2 - $56.98 $120,769 - $227,863
-3,999 Reduced 29.38%
9,613 $534,000
Q1 2020

May 05, 2020

SELL
$24.87 - $38.56 $52,152 - $80,860
-2,097 Reduced 13.35%
13,612 $403,000
Q4 2019

Feb 14, 2020

BUY
$25.43 - $36.67 $457 - $660
18 Added 0.11%
15,709 $569,000
Q3 2019

Nov 14, 2019

SELL
$23.0 - $27.97 $54,993 - $66,876
-2,391 Reduced 13.22%
15,691 $427,000
Q2 2019

Aug 07, 2019

BUY
$22.81 - $28.48 $412,450 - $514,975
18,082 New
18,082 $435,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Fifth Third Bancorp Portfolio

Follow Fifth Third Bancorp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.